Take Solutions, a technology-driven healthcare solutions provider, experienced a 1.98% increase in its share price, reaching ₹48.91 after announcing its entry into the longevity and anti-aging market in India. The company aims to create a portfolio of science-backed nutraceuticals, biohacking products, and digital wellness solutions to meet the demands of India's increasingly health-conscious consumers. This strategic move is in response to the growing global longevity market, which is expected to expand from $27.61 billion in 2025 to $67.03 billion by 2035. In India, heightened awareness of preventive healthcare and lifestyle diseases is driving the demand for anti-aging products. Take Solutions plans to leverage its existing expertise in clinical research and regulatory processes to develop clinically credible offerings. Despite this promising venture, the company reported a significant 97.67% year-on-year decline in net profit for Q3 December 2025, amounting to ₹1.11 crore, with no sales recorded in both the current and previous quarter.